Sinclair driven by Asian sales

Pharmaceutical firm Sinclair IS Pharma saw a big jump in revenues in the last year driven by international sales.

In a trading statement the firm said it expected revenue for the year to the end of June to have grown by 56% to reach £51.3m

Try 6 free issues of MoneyWeek today

Get unparalleled financial insight, analysis and expert opinion you can profit from.

Start your trial

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Chief Executive Chris Spooner put the strong performance down to a combination of strong growth from international operations, in particular Asia, and more modest like-for-like growth in Europe.

"We have continued to improve the growth prospects of our product portfolio by acquisition, and brand extension," he said.

"This combined with multiple product launches in Asia, mean that we are well positioned to deliver further growth in the coming year."

International operations saw like-for-like growth of 36% for the full year, including growth in Asia of 155% as a result of multiple product launches.

The firm said it expected international growth to continue in2013 with several new launches in Asia.

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.